diltiazem has been researched along with probucol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Achmad, TH; Rao, GS | 1 |
| Ito, M; Ohtsuka, E; Oribe, K; Oribe, M; Seita, M; Tamura, M; Ueki, Y | 1 |
| Hayashi, K; Kajiyama, G; Kuga, Y; Kuwashima, J; Nomura, K; Nomura, S; Okura, Y; Shingu, T; Tanaka, K; Yasunobu, Y | 1 |
| Koide, O; Komura, T; Kouzuma, R; Kuroiwa, A; Nakashima, Y; Tanimoto, A; Tasaki, H | 1 |
| Buxser, SE; Decker, DE; Horwitz, LD; Wallner, JS | 1 |
8 other study(ies) available for diltiazem and probucol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers.
Topics: Aspirin; Calcium Channel Blockers; Chemotaxis, Leukocyte; Diltiazem; Dose-Response Relationship, Drug; Endothelins; Humans; In Vitro Techniques; Indomethacin; Kinetics; Monocytes; Neomycin; Nifedipine; Probucol; Thioctic Acid; Verapamil | 1992 |
Probucol-induced QT prolongation and syncope.
Topics: Atrial Fibrillation; Diltiazem; Electrocardiography; Female; Humans; Hypercholesterolemia; Long QT Syndrome; Middle Aged; Probucol; Syncope | 1994 |
Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anticholesteremic Agents; Calcium Channel Blockers; Copper; Copper Sulfate; Depression, Chemical; Dibenzothiepins; Diltiazem; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Piperazines; Prazosin; Probucol | 1996 |
Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
Topics: Animals; Anticholesteremic Agents; Aorta; Arteriosclerosis; Cardiovascular Agents; Cholesterol; Cholesterol, Dietary; Diet, Atherogenic; Diltiazem; Drug Therapy, Combination; Lipoproteins; Male; Muscle, Smooth, Vascular; Phospholipids; Probucol; Rabbits; Time Factors; Triglycerides | 1995 |
Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes.
Topics: Animals; Antioxidants; Cell Death; Cell Membrane; Cells, Cultured; Chick Embryo; Chromans; Diltiazem; Dose-Response Relationship, Drug; Free Radical Scavengers; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Lidocaine; Lipid Peroxidation; Lipids; Pregnatrienes; Probucol; Propranolol; Solubility | 1996 |